Next-generation HCV treatments should benefit challenging patient groups June 13, 2016 By Jennifer Layton Dr. Michael Fried discusses exciting findings about challenging HCV patient groups with the Digestive Disease Week blog located here: Filed Under: Categories: Gastroenterology and Hepatology, News Tags: 2016 More from Department of Medicine Faculty & Staff in the News Throughout April John Buse Leads Study Finding Cushing鈥檚 Syndrome in a Quarter of Patients with Difficult-to-Control Diabetes Amanda Nelson Contributes to Landmark Osteoarthritis Study
